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The principal capsular component of Cryptococcus neoformans, glucuronoxylomannan (GXM), interacts
with surface glycans, including chitin-like oligomers. Although the role of GXM in cryptococcal infection
has been well explored, there is no information on how chitooligomers affect fungal pathogenesis. In this
study, surface chitooligomers of C. neoformans were blocked through the use of the wheat germ lectin
(WGA) and the effects on animal pathogenesis, interaction with host cells, fungal growth and capsule for-
mation were analyzed. Treatment of C. neoformans cells with WGA followed by infection of mice delayed
mortality relative to animals infected with untreated fungal cells. This observation was associated with
reduced brain colonization by lectin-treated cryptococci. Blocking chitooligomers also rendered yeast
cells less efﬁcient in their ability to associate with phagocytes. WGA did not affect fungal viability, but
inhibited GXM release to the extracellular space and capsule formation. In WGA-treated yeast cells, genes
that are involved in capsule formation and GXM trafﬁc had their transcription levels decreased in com-
parison with untreated cells. Our results suggest that cellular pathways required for capsule formation
and pathogenic mechanisms are affected by blocking chitin-derived structures at the cell surface of C.
neoformans. Targeting chitooligomers with speciﬁc ligands may reveal new therapeutic alternatives to
control cryptococcosis.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Cryptococcosis, the disease caused by the fungal pathogens
Cryptococcus neoformans and Cryptococcus gattii, kills about
650,000 people per year around the world (Park et al., 2009). Treat-
ment of human cryptococcosis is unsatisfactory in many cases (Roy
and Chiller, 2011). In this context, efforts to understand how C.
neoformans and C. gattii cause damage to the human host have
been actively pursued during the last two decades (Albuquerquell rights reserved.
volvimento Tecnológico em
, Manguinhos, 21040-360 Rio
rigues).
Paulo, Brazil.and Rodrigues, 2012) and therapeutic alternatives that neutralize
cryptococcal virulence factors could be promising alternatives to
standard antifungal therapy.
C. neoformans and C. gattii are encapsulated eukaryotic patho-
gens (Zaragoza et al., 2009). The cryptococcal capsule, which is a
major determinant of virulence, has been studied in detail in the
C. neoformans model. The capsular network consists of highly hy-
drated polysaccharides, including glucuronoxylomannan (GXM),
the most abundant component of the capsule, and glucuronoxy-
lomannogalactan (GXMGal), a minor capsular polysaccharide [re-
viewed in (Zaragoza et al., 2009)]. The complexity of the cell
surface architecture of C. neoformans is further increased by the
presence of other complex glycans, including mannoproteins, glu-
cans and chitooligomers (Rodrigues and Nimrichter, 2012). While
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last two decades (Zaragoza et al., 2009), the knowledge on how
GXMGal and mannoproteins impact cryptococcal pathogenesis
has advanced more signiﬁcantly only during last years. On the
other hand, the roles of glucans and chitooligomers in the interac-
tion of C. neoformans with host cells remain virtually unknown.
Chitooligomers or chitooligosaccharides are chitin-derived
structures composed of three to twenty residues of b1,4 linked
N-acetylglucosamine. In C. neoformans, they are embedded within
the capsular network (Fonseca et al., 2009; Rodrigues et al.,
2008) and interact with GXM to form complex glycans (Rodrigues
et al., 2008). Chitin-derived oligomers were also shown to regulate
capsular architecture in C. neoformans cells from both in vitro cul-
tures and infected tissues (Fonseca et al., 2009), implying an indi-
rect role in the cryptococcal pathogenesis. Chitooligomers have
been detected at the capsular surface (Rodrigues et al., 2008), sug-
gesting their potential for recognition by host receptors possibly
affecting cryptococcal pathogenesis.
Fungal chitooligomers are recognized with high afﬁnity by the
wheat germ lectin (WGA), a reagent that is commonly used to
study cellular distribution and functions of chitin and chitin-like
molecules (Orgad et al., 1984). The addition of WGA to Fusarium
sp cultures resulted in morphological alterations of the germ tubes,
including vacuolation of the cellular content and lysis of cell walls,
culminating in the prevention of spreading of the fungus within
the host (Ciopraga et al., 1999). Indeed, chitin-derived oligomers
have been implicated with cell division in different models (Chen
and Contreras, 2004).
Considering the virtually unknown role of chitin-derived oligo-
mers in the pathogenesis of fungal infections and their recently de-
scribed functions in the physiology of C. neoformans (Fonseca et al.,
2009; Rodrigues et al., 2008), we aimed at determining how these
molecules affect pathogenic mechanisms of this fungus. Based on a
model where chitooligomer exposure at the cell surface was
blocked with WGA, we demonstrated that these glycans are in-
volved in brain colonization of mice and interaction with phago-
cytes. Unexpectedly, blocking of chitooligomers with the lectin
resulted in defective capsule formation and down regulation of
genes required for synthesis, cellular trafﬁc and signaling path-
ways controlling capsular components. These results reveal novel
functions for surface glycans in C. neoformans.2. Methods
2.1. Microorganism and growth conditions
The C. neoformans strain used in all experiments in this study
was the standard serotype A isolate H99 (Loftus et al., 2005). The
only exception was the use of the C. gattii standard serotype B
strain R265 (Gillece et al., 2011) as a control in scanning electron
microscopy procedures utilizing the lectin WGA as an inhibitor of
capsule formation. Yeast cells were inoculated into 100 ml Erlen-
meyer ﬂasks containing 50 ml of minimal medium composed of
glucose (15 mM), MgSO4 (10 mM), KH2PO4 (29.4 mM), glycine
(13 mM), and thiamine-HCl (3 lM) (pH 5.5). Fungal cells were cul-
tivated for 2 days at 30 C, with shaking. Yeast cells were obtained
by centrifugation, washed in phosphate-buffered saline (PBS) and
counted in Neubauer chamber. All media were prepared with apyr-
ogenic water, and glassware was rendered sterile and pyrogen free
by heating to 190 C for 4 h.2.2. Macrophages
Bone marrow-derived macrophages (BMDM) were obtained
from wild type (WT) or Tlr2/ mice (C57BL/6, gender matched,6–10 week old) (Marim et al., 2010). The animals were kept at
25 C with free access to chow and water in a room with a 12-h
light/dark cycle. The Animal Ethics Committee at the Federal Uni-
versity of Rio de Janeiro approved the animal protocols. Bone mar-
row was harvested from the tibias and femurs from mice and
differentiated into BMDM as described previously (Marim et al.,
2010). The cells were suspended at 5  106/10 ml in RPMI 1640
medium supplemented with 20% of FCS and 30% of supernatant
from L929 cells cultures. After 3 days, fresh supplemented medium
was added to the cell cultures. Macrophages were collected at day
6, and 5  105/well were plated in 24-well plates in RPMI 1640
medium with 10% of FCS. Cells were cultivated at least 12 h before
further experimental procedures.
2.3. Interaction of C. neoformans with mammalian cells
For interaction with host cells, control fungi or WGA-treated
cryptococci were used. Treatment with WGA consisted of incuba-
tion of yeast cells (5  106 cells/ml) for 30 min at 37 C with the
lectin at 10 lg/ml in PBS. The cells were washed in PBS by centri-
fugation and then stained with 0.5 mg/ml ﬂuorescein isothiocya-
nate (FITC; Sigma) in PBS (25 C) for 10 min (Barbosa et al.,
2006). Staining with FITC was monitored by ﬂow cytometry and
ﬂuorescence microscopy, which revealed that both control and
WGA-treated fungi had similar levels of ﬂuorescence (data not
shown). Fungal suspensions were prepared in DMEM at a ratio of
10 yeasts per host cell. Interactions between fungal and host cells
occurred at 37 C with 5% CO2 for 12 h. Incubation time was based
on previous phagocytosis studies developed in our laboratory
showing that 60–70% of the phagocytes become infected and efﬁ-
ciently internalize C. neoformans after overnight incubations in the
absence of opsonins (Kmetzsch et al., 2011a,b,c, 2010). In some
systems, the medium of interaction was supplemented with the
trisaccharide (GlcNAc)3 at 10 lg/ml (Sigma; Richmond, VA). Cells
were washed three times with PBS to remove non-adherent yeasts.
After removal from the plastic surface with a cell scrapper, the cells
were analyzed by ﬂow cytometry as described previously (Barbosa
et al., 2006). Control preparations were developed as described
above by using uninfected cells and non-stained yeast (data not
shown).
2.3.1. Animal infection
Before infection, fungal suspensions were treated for 1 h at
37 C with PBS (control) or with the same buffer supplemented
with WGA (10 lg/ml, ﬁnal concentration). The cells were then
washed with PBS to remove unbound WGA, collected by centrifu-
gation and adjusted to the density of 106 yeast cells per 50 ll of
PBS. Female BALB/c mice (6–8 weeks old, n = 10) were ﬁrst submit-
ted to anesthesia through intraperitoneal administration of keta-
mine (10 mg/kg) and xylazine (4 mg/kg). The fungal suspension
was then inoculated intratracheally. Alternatively, mice were in-
fected with C. neoformans as described above, but with no previous
treatment with WGA. In these systems, mice were given WGA dur-
ing infection in ﬁve doses with 48 h intervals. The ﬁrst dose was
administered 24 h after infection. Each dose corresponded to
50 ll PBS containing 10 lg of WGA, to mimic the lectin-crypto-
cocci ratio (10 lg/106 cells) used in the in vitromacrophage assays.
Control systems included infected mice given similar volumes of
PBS. To evaluate whether WGA alone could induce acute toxicity,
the lectin was also administered to uninfected mice in a similar
fashion, with all animals remaining alive for at least 30 days (data
not shown). Animals were monitored daily for mortality or, alter-
natively, sacriﬁced 5 days post-infection for counting colony form-
ing units (CFUs). For this analysis, brains and lungs were excided,
macerated in PBS and plated onto Sabouraud dextrose agar, as pre-
viously described (Rodrigues et al., 2007b). Histopathologic analy-
Table 1
List of primers used in qRT-PCR.
Gene Accession numbera Primer Sequence (50–30)
CAP59 CNAG_00721 CnCAP59F AACCCGAACGAAGAAACCTC
CnCAP59R ACCCCAGCACCACACATACTC
CAP64 CNAG_02885 CnCAP64F ACAAGGAAAGGGCATTCAGAG
CnCAP64R TATCACTGGGACGGTCAGAAAG
CAP10 CNAG_07554 CnCAP10F TCTTCTTCCGTCATTCGTTC
CnCAP10R TTCTCCCGTACCTCTTCTTG
PKA1 CNAG_00396 CnPKA1F CTGAACGAGAGATGTTGGTAC
CnPKA1R GCTGACTTTTACGAAGAAGG
MAN1 CNAG_04312 CnMAN1F TTGATGAGAAGCCTGATGTC
CnMAN1R TAGGGATTCGGTGAGAGAAG
GPA1 CNAG_04505 CnGPA1F GATGAGGCTGATGTTCTGAG
CnGPA1R CTTCTTTCTCTCGCTTCTCTG
CMT1 CNAG_03158 CnCMT1F CTCGTACAGCCTATTCCAAC
CnCMT1R GACATCACCTCTCCTGAAAC
GRASP CNAG_03291 CnGRASPF GAGGGAGAGGGAATAGTAGTG
CnGRASPR CTTTTGACGCTTCTTCTGAC
CAP60 CNAG_00600 CnCAP60F CGCATATTACCCCCTTGAAG
CnCAP60R CGGCATTGTTGAGTTGACTG
ACT1 CNAG_00483 CnACTF CCTTGCTCCTTCTTCTAT
CnACTR CTCGTCGTATTCGCTCTT
TUB CNAG_01840 CnTUBF TGTCCTCTACCTTCATTTGC
CnTUBR CCATACCCTCTCCAGTGTAC
a Cryptococcus neoformans H99 Genome Database at Broad Institute – http://
www.broadinstitute.org/annotation/genome/cryptococcus_neoformans/MultiHome.
html. Gene products are phosphomannose isomerase 1 (MAN1), a-1,3-mannosyl-
transferase (CMT1), Golgi reassembly and stacking protein (GRASP), capsule-related
(CAP) proteins 59, 10, 64 and 60, G-protein alpha subunit 1 (GPA1), cyclic AMP
(cAMP)-dependent protein kinase catalytic subunit 1 (PKA1) and actin (ACT1).
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groups, the lung right upper lobe was removed and placed into for-
malin for histology. Formalin-ﬁxed, parafﬁn-embedded tissues
were examined with hematoxylin-eosin for evaluation of histopa-
thology and fungal distribution. Local ethics committees at both
Albert Einstein College of Medicine and University of São Paulo ap-
proved protocols for animal experimentation.
2.3.2. Susceptibility of WGA to the activity of peptidases
To evaluate the possibility of WGA degradation by host pepti-
dases and loss of biological activity during infection, samples of
TRITC-lectin (5 lg/ml) were incubated in PBS alone or in the same
buffer supplemented with trypsin (100 lg/ml, pH 8.0) for 16 h at
37 C. Alternatively, the lectin was incubated under the same con-
ditions in human or mouse sera. These samples were then used to
stain C. neoformans, followed by analysis by ﬂuorescence micros-
copy as previously described (Rodrigues et al., 2008). Our parame-
ter to analyze the integrity of the lectin and/or retaining of
biological activity was the ability to produce the typical polarized
pattern of staining of budding sites (Fonseca et al., 2009; Rodrigues
et al., 2008).
2.4. Effects of WGA on polysaccharide extracellular release, capsule
formation and fungal viability
C. neoformans cells were ﬁrst cultivated for 24 h at room tem-
perature in liquid Sabouraud medium, a condition at which capsule
formation is impaired (Zaragoza and Casadevall, 2004). To stimu-
late capsule production, fungal cells (106 cells/ml) were transferred
to minimal medium and cultivated for 48 h at room temperature.
This assay included systems in which the medium was supple-
mented with WGA at concentrations varying from 10 to 1000 lg/
ml. Fungal growth was monitored spectrophotometrically (absor-
bance at k = 600 nm) during 48 h in 12 h-intervals. Cells were har-
vested by centrifugation and tested for capsule formation by
counter-stained with India ink and immunoﬂuorescence as previ-
ously described (Fonseca et al., 2009; Rodrigues et al., 2008). Alter-
natively, the cells were plated onto Sabouraud agar for CFU
quantiﬁcation. For scanning electron microscopy, fungal cells were
ﬁxed in 4% glutaraldehyde for 1 h at room temperature. The cells
were then placed onto poly-L-lysine-coated coverslips and submit-
ted to dehydration and critical point drying with CO2. Samples
were mounted with gold–palladium and viewed with a Quanta
50 scanning electron microscope. Supernatants were collected for
GXM determination by ELISA as described before (Casadevall
et al., 1992). In both ELISA and immunoﬂuorescence tests, the
monoclonal antibody to GXM 18B7 (mAb 18B7) (Casadevall
et al., 1998) was used. Importantly, serologic reactions of mAb
18B7 with cryptococcal GXM are not affected by the presence of
varying concentrations of WGA (Fonseca et al., 2009).
2.5. Quantitative real time RT-PCR analysis
Two sets of RNA samples from independent experiments using
control cryptococci or yeast cells were prepared using Trizol re-
agent (Invitrogen) according to the manufacturer’s protocol. For
RNA extraction, yeast cells (106 cells/ml) were incubated in mini-
mal medium supplemented with WGA (500 lg/ml) for 48 h at
room temperature, as described in the item above. After DNase
treatment, RNA preparations were utilized for ﬁrst-strand synthe-
sis of cDNA using M-MLV reverse transcriptase (Promega).
Real-time PCR reactions were performed in an Applied Biosystems
StepOnePlus Real-Time PCR System. PCR thermal cycling condi-
tions were an initial step at 95 C for 5 min followed by 40 cycles
at 95 C for 15 s, and 60 C for 1 min. Platinum SYBR Green qPCR
SuperMix-UDG with ROX (Invitrogen) was used as reaction mix,supplemented with 4 pmol of each primer and 2 ll of the cDNA
template in a ﬁnal volume of 20 ll. All experiments were done in
duplicate and each cDNA sample was analyzed in triplicate with
each primer pair. Melting curve analysis was performed at the
end of the reaction to conﬁrm a single PCR product. Data was nor-
malized to actin gene cDNA ampliﬁed in each set of PCR experi-
ments. Relative expression was determined by the 2DCT method
(Livak and Schmittgen, 2001). The primers utilized in these exper-
iments are listed in Table 1.
2.6. Statistical analysis
Student’s t test was used for comparison of two different groups
and one-way ANOVA was used for comparison of several groups.
Mice survival was statistically analyzed through the use of the
Kaplan–Meier test. Statistical tests were performed with GraphPad
Prism (version 5.0).
3. Results
3.1. Chitooligomers participate in C. neoformans animal pathogenesis
The possibility that chitin-like structures might contribute to
the pathogenesis of C. neoformans (Fonseca et al., 2009; Ramos
et al., 2012; Rodrigues et al., 2008; Rodrigues and Nimrichter,
2012) led us to evaluate whether blocking the formation of these
molecules would inﬂuence the course of animal cryptococcosis.
We therefore aimed at interfering with the exposure of chitooligo-
mers by blocking C. neoformans cells with WGA before infection of
mice. In these experiments, mice infected with untreated C. neofor-
mans displayed regular symptoms of murine pulmonary crypto-
coccosis, characterized by partial loss of appetite and apparent
depression. At 10 days post-infection, an increase in the respiration
rate was noted and within 15–20 days, symptoms gradually ad-
vanced to signiﬁcant anorexia, lethargy, loss of hair arrangement
and tachypnea. Within a 20–30 days interval, animals became
Fig. 1. Blocking chitooligomers at the surface of C. neoformans altered the course of animal cryptoccocosis in favor of the host. (A) Comparison of mortality rates between
animals infected with control cryptococci or with WGA-treated yeast cells revealed that the previous exposure of fungal cells to the lectin caused attenuation in the ability of
C. neoformans to kill mice (n = 10). Determination of fungal burden in lungs (B) and brains (C) of infected animals (n = 5) indicated that lectin binding resulted in decreased
ability to colonize the central nervous system (P = 0.0164), but not the lung (P = 0.8274). Data in A–C are representative of two independent experiments with similar results.
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symptoms, although they were apparent with a 3–5 days delay
in comparison with control mice. These observations were in
agreement with the fact that pretreatment of yeast cells with the
chitooligomer-binding lectin attenuated the ability of C. neofor-
mans to kill mice (Fig. 1A). This observation in association with
the delayed manifestation of systemic symptoms led us to suppose
that infection with WGA-treated C. neoformans could have altered
kinetics of dissemination. Indeed, WGA-treatment was associated
with a severe deﬁciency in the capacity of yeast cells to colonize
the brain of animals at day 5 post-infection (Fig. 1B and C), sug-
gesting that the structures blocked by WGA could be involved with
fungal dissemination.
The fact that WGA-treated cryptococci were initially con-
tained in the lung raised several hypotheses to explain the inef-
ﬁciency of these cells to reach the brain at early stages of
infection. We ﬁrst considered the possibility that cell wall-bound
WGA could stimulate cellular inﬂammatory responses in the
lung resulting in control of dissemination, based on the fact that
pulmonary inﬂammatory processes are crucial for the local con-
trol of cryptococcosis (Goldman et al., 1994). Histopathological
analysis of animals that were infected with C. neoformans or
with WGA-treated yeast cells revealed that both systems pro-
duced similar proﬁles (Fig. 2A), implying that wall-associated
WGA did not affect the cellular inﬂammatory response in the
lungs of infected animals. These initial observations strongly
suggested that blocking of C. neoformans chitooligomers would
affect only the initial interactions of the fungus with host cells,
since the cryptococcal progeny would not carry WGA. To evalu-
ate this hypothesis, WGA was administered during mouse infec-
tion instead of being used to coat C. neoformans before animal
inoculation. In contrast to what has been observed when the
fungus was treated with WGA before inoculation, administration
of WGA during animal cryptococcosis did not interfere with the
course of infection (Fig. 2B). One possible explanation for this
ﬁnding would be related to the degradation of soluble WGA by
host’s proteases with consequent loss of capacity to recognize
chitooligomers. To rule out this possibility, TRITC-WGA was
incubated with PBS (control), trypsin, human or mouse fresh
sera. In all cases, the lectin retained the ability to produce stain-
ing proﬁles of C. neoformans that were similar to those produced
after incubation under control conditions (Fig. 2C). This observa-
tion suggested that even if WGA was partially degraded by
host’s peptidases, the properties related to chitooligomer binding
were retained. These results also ruled out the possibility that
WGA was acting as an immune modulator in favor of the host,since no protective effect was observed when the lectin was
used to treat cryptococcal infection.3.2. Chitooligomers are involved in the recognition of C. neoformans by
animal macrophages
Recently, the ability of macrophage TLR2 to interact with chitin
fragments was characterized (Da Silva et al., 2009), suggesting that
this could also be the receptor for the cryptococcal chitin-like mol-
ecules. In addition, macrophages are supposed to play central roles
in initial interactions of host cells with C. neoformans (Del Poeta,
2004) and in dissemination to the brain (Kechichian et al., 2007).
We then analyzed the levels of association between yeast cells
and macrophages obtained from wild type (WT) or Tlr2/ mice.
Approximately 75% of the WT macrophages were infected with C.
neoformans (Fig. 3). This value, which was in agreement with pre-
vious studies using similar models (Kmetzsch et al., 2011a,b,c,
2010), was about threefold higher than the percentage of Tlr2/
macrophages infected by C. neoformans. Blocking of fungal chitoo-
ligomers with WGA before incubation with BMDM caused a de-
crease of approximately 50% in the efﬁcacy of association of C.
neoformans with macrophages obtained from WT mice. In systems
using macrophages from Tlr2/ mice, WGA did not exert any
inhibitory effect. The lectin did not inﬂuence phagocytosis levels
of C. neoformans by WT and Tlr2/ macrophages in systems
where it was used to supplement the interaction medium instead
of coating yeast cells (data not shown). Finally, the levels of asso-
ciation of cryptococci with macrophages in the presence of a solu-
ble chitooligomer, (GlcNAc)3 were evaluated. The efﬁcacy of C.
neoformans to associate with WT macrophages was decreased in
approximately 25% in the presence of the chitooligomer. However,
in accordance with results obtained with WGA-treated fungi, (Glc-
NAc)3 did not cause any inhibition in the association of Tlr2/
macrophages with C. neoformans.. Taken together, these results
suggest that C. neoformans chitooligomers are recognized by host
macrophages through surface TLR2.3.3. Blocking of C. neoformans chitooligomers with WGA affects
extracellular release of GXM, but not fungal viability
Capsule formation is fundamental for the outcome of the inter-
action of C. neoformans with macrophages and for fungal virulence
(Zaragoza et al., 2009). The fact that GXM associates with chitoolig-
omers (Fonseca et al., 2009; Rodrigues et al., 2008) and the key
contribution of this polysaccharide to fungal virulence (Zaragoza
Fig. 2. Inﬂuence of WGA on pathophysiologic aspects of mice infected with C. neoformans. (A) Histology of lungs 5 days after intratracheal infection with C. neoformans.
Similar pulmonary histologic proﬁles of mice receiving PBS, C. neoformans and WGA-treated cryptococci are shown. Some of the fungal cells identiﬁed in the images are
highlighted with arrows. Images are representative of similar sections from mice in each group (n = 10). Original magniﬁcation 100. (B) Treatment of lethally infected mice
with WGA did not inﬂuence the course of animal cryptococcosis. Mice given PBS or WGA had similar mortality rates (n = 10, P = 0.7124). (C) Incubation of the lectin in the
presence of PBS (control), trypsin or serum did not result in loss of its ability to recognize C. neoformans, as concluded by the similar proﬁles of ﬂuorescence staining in all
systems. The patterns of lectin staining in all cases corresponded to those described in previous studies (Fonseca et al., 2009; Rodrigues et al., 2008).
Fig. 3. Chitooligomers are required for association of C. neoformans with phagocytes. The efﬁcacy of association of C. neoformans (Cn) with macrophages obtained from WT
animals (upper panel) was much higher than that observed when macrophages from Tlr2/ mice were used (lower panel). Treatment of C. neoformans cells with WGA
before exposure to host cells affected the interaction of fungi with macrophages from WT animals, but not with the phagocytes obtained from Tlr2/ mice. Incubation of
fungal cells with macrophages in the presence of the chitooligomer (GlcNAc)3 resulted in decreased levels of infection of WT macrophages, but not of the Tlr2/ phagocytes.
Results illustrated in this ﬁgure are representative of three independent experiments.
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formation and polysaccharide release to the extracellular space.
WGA did not induce a general failure in C. neoformans secretory
processes, since protein secretion was not inhibited by treatment
of yeast cells with WGA (Fonseca, unpublished data). After expo-sure to the lectin, however, C. neoformans cells manifested clear de-
fects to produce extracellular GXM (Fig. 4). Decreased extracellular
GXM release could also be related to lectin-induced cell death
(Ciopraga et al., 1999; Mirelman et al., 1975). Determination of
fungal viability after treatment with WGA, however, revealed that
Fig. 4. Treatment of C. neoformans with WGA affects polysaccharide secretion, but not cell viability or serologic properties of GXM. (A) Incubation of cryptococci with WGA
followed by GXM determination in supernatants revealed a dose-dependent inhibition of polysaccharide extracellular release. (B) Immunoﬂuorescence microscopy
demonstrating that exposure of C. neoformans to WGA did not affect the recognition of GXM by a monoclonal antibody raised to the polysaccharide. Analysis of fungal
proliferation by CFU counting (C) or culture spectrophotometry (D) revealed that growth rates were similar in control systems (CT, incubated in the absence of the lectin) or in
cultures that were supplemented with WGA.
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polysaccharide quantiﬁcation was based on ELISA we had to ex-
clude the possibility that false-negative results were obtained
due to structural modiﬁcations of the polysaccharide and conse-
quent loss of serological reactivity. Therefore, C. neoformans cells
were stained with a monoclonal antibody to GXM after incubation
with WGA showing that the polysaccharide was regularly recog-
nized by the antibody after incubation of fungal cells with the lec-
tin (Fig. 4). Lectin-treated cells, however, had an apparent
reduction in capsular dimensions. This observation and the fact
that extracellular release of GXM is mandatory for capsule enlarge-
ment (Zaragoza et al., 2006) led us to evaluate the effects of chitoo-
ligomer blocking on capsule formation.
Both visual and quantitative determinations demonstrated that
WGA caused a clear dose-dependent inhibition of capsule forma-
tion (Fig. 5). Since the mechanisms by which carbohydrate-binding
proteins interfere with capsule formation are unknown, we se-
lected conditions that combined maximal values of fungal viability
with clear alterations in capsule formation for further investiga-
tion. Scanning electron microscopy analysis revealed that exposure
of C. neoformans to WGA at 500 lg/ml induced a clear inhibition of
capsule formation (Fig. 6A). This effect was exclusively observed
when C. neoformans was exposed to the lectin, since the capsule
of C. gattii was not affected by treatment with WGA at the same
concentration. Under these conditions, the serological properties
of surface GXM were preserved (Fig. 6B and C). Extracellular
GXM was markedly decreased after exposure of C. neoformans to
the lectin at this concentration (Fig. 6D). Based on these results,
we selected the 500 lg/ml lectin concentration for evaluation of
transcription levels of capsule-related genes.
3.4. Binding of C. neoformans chitooligomers to WGA reduces the
transcription levels of genes involved with capsule formation
Capsule formation requires the synthesis of the basic GXM com-
ponents (Klutts et al., 2006), the transport of newly formed poly-saccharides to the extracellular space (Casadevall et al., 2009;
Kmetzsch et al., 2011a; Rodrigues et al., 2007a; Yoneda and Doer-
ing, 2006), and their assembly at the fungal cell surface (Doering,
2009; Zaragoza et al., 2009). These events were the basis for selec-
tion of genes whose products were previously demonstrated to
regulate capsule formation. These genes, which included GPA1
(Alspaugh et al., 1997), PKA1 (D’Souza et al., 2001), CAP10 (Chang
and Kwon-Chung, 1999), CAP60 (Chang and Kwon-Chung, 1998),
CAP59 (Chang et al., 1995; Garcia-Rivera et al., 2004), CAP64 (Chang
et al., 1996), GRASP (Kmetzsch et al., 2011a), CMT1 (Sommer et al.,
2003), and MAN1 (Wills et al., 2001), had their transcription levels
tested after binding of WGA to C. neoformans cells. The relative
expression of b-tubulin was evaluated as a control, to rule out
the possibility that WGA treatment would cause a non-speciﬁc glo-
bal reduction in gene expression. In accordance with viability data
(Fig. 4), the transcription levels of b-tubulin were not affected in
lectin-treated cells (Fig. 7; P = 0.8201 after comparison with un-
treated yeast cells).
WGA binding negatively modulated the transcription of nine
different genes required for capsule formation (Fig. 7). MAN1 and
CMT1, which are both essential for mannose metabolism (Sommer
et al., 2003; Wills et al., 2001), had their transcription signiﬁcantly
reduced inWGA-treated cells (P < 0.0003 and 0.0001, respectively).
GRASP and CAP59 were described to be required for the trafﬁc of
GXM (Garcia-Rivera et al., 2004; Kmetzsch et al., 2011a). Both
genes had their transcription reduced in lectin-treated cells
(P < 0.0001 for both systems). Other CAP genes, including CAP10,
CAP60 and CAP64 (Chang et al., 1997, 1996,1995; Chang and
Kwon-Chung, 1998, 1999), were also negatively affected by lectin
treatment (P < 0.0001 for CAP10 and CAP64 and 0.0006 for
CAP60). The transcription levels of PKA1 and GPA1, which are key
regulators of signaling pathways required for capsule formation
(Alspaugh et al., 1997; D’Souza et al., 2001), were also evaluated.
While exposure to WGA strongly affected the transcription of
PKA1 (P < 0.0001), the effect of the lectin over the expression of
GPA1 was discrete, although statistically signiﬁcant (P < 0.006). To-
Fig. 5. WGA affects capsule formation in C. neoformans. Capsular morphology and dimensions were analyzed visually after counter-staining of yeast cells with India ink as
illustrated in A for microscopic determination of capsule size (B). Scale bar corresponds to 10 lm.
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cells efﬁciently attenuates the expression of genes involved in cap-
sule formation.4. Discussion
A number of studies have consistently demonstrated that GXM
is the most important surface component of C. neoformans [re-
viewed in (Zaragoza et al., 2009)]. However, it is now clear that
other glycans contribute to the architecture and functions of the
capsule. Therefore, a realistic perspective is that many aspects re-
lated to the biological roles of surface components in C. neoformans
require clariﬁcation.
Chitooligomers have been detected within the capsular matrix
in both C. neoformans and C. gattii (Rodrigues et al., 2008). These
oligosaccharides interact with GXM forming hybrid molecules that
are apparently relevant for the architecture of the capsule, cellular
responses and possibly interaction with the host (Fonseca et al.,
2009; Ramos et al., 2012; Rodrigues et al., 2008; Rodrigues and
Nimrichter, 2012). Chitooligosaccharides were also detected in
outer layers of the capsule (Rodrigues et al., 2008), but their func-
tions during the interaction of C. neoformans with host cells have
not been explored thus far. Fungal chitin is normally not accessible
to the immune system, but its smaller fragments have been dem-
onstrated to be efﬁcient immune modulators (Da Silva et al.,
2009), in addition to being exposed at the surface of C. neoformans
(Rodrigues et al., 2008).
Here we demonstrated that the pathogenesis of mice cryptococ-
cosis was altered when infection was performed withWGA-treated
C. neoformans cells. Lectin treatment was associated to an attenu-
ated ability of C. neoformans to kill mice and failure in early coloni-
zation of the central nervous system. Noteworthy, the totality of
animals infected with WGA-treated yeast cells died 34 days after
infection. We believe this observation is in agreement with the fact
that, in our model, the cryptococcal progeny generated during
infection will not carry surface-bound WGA, limiting the eventual
effects of the lectin to early pathogenic mechanisms. Therefore,one would indeed expect that infection of mice with lectin-treated
cells results in virulence attenuation rather than in a dramatic
alteration of the course of mice cryptococcosis in favor of the host.
This supposition would be in agreement with the observation that
WGA did not affect fungal proliferation, which could result in the
recovery of the pathogenic potential by C. neoformans after a few
rounds of replication.
Early steps of entrance of cryptococci into the central nervous
system involves multiple mechanisms that may include breakage
of alveolar barriers, direct invasion of brain endothelial cells, ure-
ase-dependent passage through the brain microvasculature and
‘‘Trojan horse’’ pathways whereby cryptococci enter the brain after
macrophage ingestion (Casadevall, 2010; Charlier et al., 2009;
Kechichian et al., 2007). Considering that phagocytosis is a key
event in the pathogenesis of C. neoformans (Del Poeta, 2004) and
that intracellular macrophage parasitism is believed to be advanta-
geous to the fungus (Feldmesser et al., 2001), we speculate that
blocking chitooligomers could be linked to a decreased efﬁcacy
in intracellular parasitism and to faulty dissemination to the brain
by ‘‘Trojan horse’’-related mechanisms. The fact that WGA-treated
cryptococci were initially contained in the lung, however, raised
several hypotheses to explain the reduced efﬁciency of these cells
to reach the brain. Since pulmonary inﬂammatory processes are
crucial for the local control of cryptococcosis (Goldman et al.,
1994), cell wall-bound WGA could stimulate cellular inﬂammatory
responses in the lung resulting in control of dissemination. How-
ever, the histopathological features of the lungs of animals that
were infected with untreated C. neoformans or with WGA-treated
yeast cells were similar, suggesting that wall-associated lectin
did not affect the local inﬂammatory response. Administration of
WGA during mouse infection instead of using the lectin to coat C.
neoformans before animal inoculation did not interfere with the
course of infection, although WGA retained its primary biological
activity (chitooligomer binding) even after exposure to host’s pro-
teases. Therefore, we considered unlikely the possibility that WGA
was acting as an immune modulator in favor of the host.
It has been recently demonstrated that the efﬁcacy of the inter-
action of TLR2 with chitin is inversely related to the dimensions of
Fig. 6. Phenotypic analysis of capsule formation in C. neoformans after exposure of the fungus to WGA at 500 lg/ml. Scanning electron microscopy (A) demonstrated that
capsular dimensions of C. neoformans, but not of C. gattii, were affected by treatment with WGA. Capsule morphology is shown for samples of C. neoformans and C. gattii
populations (left panels; scale bar, 5 lm) and for individual cells (right panels; scale bar, 2 lm). SEM observations of C. neoformans correlate with the phenotype observed by
India ink counter staining (B, upper panels) and with the regular recognition of surface polysaccharides by a monoclonal antibody to GXM, as demonstrated by
immunoﬂuorescence microcopy (B, lower panels) and ﬂow cytometry (C). Under this condition, the concentration of extracellular GXM is signiﬁcantly smaller in culture
supernatants of WGA-treated cells (D, P < 0.00001).
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ognition of chitin fragments by TLR2 stimulates IL-17 production
(Da Silva et al., 2008). In the C. neoformans model, the inﬂuence
of TLR2 on the efﬁcacy of the immune response is controversial.
Nakamura and colleagues suggested that TLRs 2 and 4 would have
a limited contribution to the host’s anti-cryptococcal response
(Nakamura et al., 2006), but independent studies demonstrated
that IL-17 (Wozniak et al., 2011) and TLR2 (Levitz, 2002, 2004;
Yauch et al., 2005, 2004) are potentially involved in the anti-cryp-
tococcal pulmonary defense. The latter reports suggest that block-
ing small chitin fragments or chitooligomers might affect the
interaction of C. neoformanswith host cells by interfering with fun-gal surface ligands that would be potentially recognized by host
cell receptors. Indeed, we observed that TLR2 was involved in the
chitooligomer-mediated phagocytosis of C. neoformans by macro-
phages. Blocking of the glycans with WGA also decreased the abil-
ity of yeast cells to associate with the phagocytes. It is unlikely that
the effects of WGA on capsular assembly inﬂuenced this result, be-
cause the concentration used to block chitooligomers in phagocy-
tosis assays was much smaller than that affecting the
cryptococcal capsule. The observation that macrophages use TLR2
to interact with C. neoformans is in agreement with previous re-
ports on the role of TLRs as mediators of processes of interaction
of fungal molecules with phagocytes (Bittencourt et al., 2006;
Fig. 7. Treatment of C. neoformans with WGA affects the transcript levels of genes required for capsule formation. The relative expression of b-tubulin (TUB),
phosphomannose isomerase 1 (MAN1), a-1,3-mannosyltransferase (CMT1), Golgi reassembly and stacking protein (GRASP), capsule-related (CAP) proteins 59, 10, 64 and 60,
G-protein alpha subunit 1 (GPA1) and cyclic AMP (cAMP)-dependent protein kinase catalytic subunit 1 (PKA1) was quantiﬁed by qRT-PCR. RNA amounts in each sample were
normalized using the threshold cycle (CT) values obtained for the actin gene.
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mediated recognition of chitooligomers to the immunity to C. neo-
formans is uncertain, but our results indicate that these glycans can
at least participate in the process of recognition of the pathogen by
immune cells.
In our study, WGA exerted important biological activities in
variable concentrations. We have previously demonstrated that
virtually 100% of the C. neoformans population stains positively
for WGA at concentrations lower than 10 lg/ml, without affecting
capsular dimensions (Fonseca et al., 2009; Rodrigues et al., 2008).
Since capsular dimensions are determinant for interaction of C.
neoformans with host cells [reviewed in (Zaragoza et al., 2009)],
experiments aiming at evaluating the pathogenesis-related func-
tions of chitooligomers were developed under conditions at which
the capsule was not affected (10 lg/ml). On the other hand, in
experiments focused on the ability of WGA to interfere with capsu-
lar architecture and gene expression, an experimental condition
combining maximal values of fungal viability with unquestionable
alterations in capsule formation was required (500 lg/ml). In this
context, treatment of C. neoformanswith WGA could interfere with
polysaccharide synthesis, promoting a general attenuation in GXM
metabolism, or simply block polysaccharide secretion. It has been
described that binding of lectins to the surface of eukaryotic cells
can profoundly modify intracellular signaling cascades and regu-
late gene expression (O’Brien et al., 2012; Zou et al., 2012). In fact,
we observed that WGA caused an effective ablation of transcrip-
tion levels of eight genes directly or indirectly involved in capsule
formation and a discrete attenuation in the transcription of the
gene encoding the subunit a of protein G, an important mediator
of signaling pathways in C. neoformans (Alspaugh et al., 1997;
D’Souza et al., 2001). Some of the functional products of the genes
evaluated in this study are not physiologically connected, which
may suggest that WGA could simply promote a general attenuation
in gene expression. However, the facts that the fungal viability was
not affected by the lectin and that the expression of a capsule-
unrelated gene was not inﬂuenced by WGA argue against thishypothesis. The diminished transcription levels of the genes
encoding Gpa1p and Pka1p, in addition, could explain the global
effects observed in our study. Down-regulation of the expression
of GPA1 and PKA1 could affect the intracellular signaling cascades
that regulate capsule formation, as proposed in previous studies
(Alspaugh et al., 1997; D’Souza et al., 2001). These events and re-
lated phenomena in C. gattii are under investigation in our
laboratory.
Mechanisms connecting binding of external ligands to capsular
glycomolecules with activation of intracellular signaling pathways
are virtually unknown. However, WGA binds to some areas of the
capsule and antibody binding to the capsule is known to trigger
gene expression changes in C. neoformans (McClelland et al.,
2010). Recently antibody binding has been shown to alter the
mechanical properties of the polysaccharide capsule (Cordero
et al., 2013) and it is possible that chitin oligosaccharides mediate
similar phenomena that are sensed by the fungal cell resulting in a
disruption in capsule synthesis. Our current results add chitooligo-
mers to the list of surface components of C. neoformans interfering
with fungal pathogenesis. Thus, it seems plausible to suppose that
molecules with the ability to speciﬁcally block surface exposure of
chitooligosaccharides in C. neoformans could have therapeutic po-
tential. In this context, the production of chitooligomer-binding
peptides and monoclonal antibodies raised to these glycans could
represent promising strategies aiming at controlling
cryptococcosis.
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